Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Develops and markets drugs focused on the treatment of obesity.
Year Established: | |
Funding: | |
Address: | Wilmington, DE 19810 |
Telephone: | 2147483647 |
Mobile: | |
Fax: | (801) 218-1233 |
Mail: | |
Company URL: | http://www.jenrindiscovery.com |
Ben Franklin Technology Partners Southeastern PA
John McElroy, Ph.D., founder, President and CSO Formerly, Dr. McElroy was Director of Neuroscience Biology at Bristol-Myers Squibb. His 16 years of pharmaceutical industry experience also includes roles at Burroughs Wellcome and DuPont Pharmaceuticals, 5 clinical development candidates, 9 patents and over 40 publications. He has Doctoral and Postdoctoral experience investigating central and peripheral mechanisms of metabolic disorders. Dr. McElroy received his Ph.D. in pharmacology from the University of Massachusetts.
Robert Chorvat, Ph.D., Vice President Chemistry Dr. Robert Chorvat leads the Medicinal Chemistry effort and is responsible for the identification and preparation of proprietary compounds that are expected to meet the program requirements of Jenrin Discovery, as well as crafting the patent applications covering these agents. He has more than 30 years of management experience in the pharmaceutical industry where he headed medicinal chemistry groups at Searle/Monsanto, DuPont Medical Products, DuPont-Merck and DuPont Pharmaceuticals (now Bristol Meyers Squibb). Dr. Chorvat